Reference |
---|
Bouchet C, Miner M, Loetz E, Rosberg A, Hake H, Farmer C, et al. Activation of Nigrostriatal Dopamine Neurons during Fear Extinction Prevents the Renewal of Fear. Neuropsychopharmacology. 2017;: pubmed publisher
|
Gore B, Zweifel L. Genetic reconstruction of dopamine D1 receptor signaling in the nucleus accumbens facilitates natural and drug reward responses. J Neurosci. 2013;33:8640-9 pubmed publisher
|
Ericsson J, Stephenson Jones M, Pérez Fernández J, Robertson B, Silberberg G, Grillner S. Dopamine differentially modulates the excitability of striatal neurons of the direct and indirect pathways in lamprey. J Neurosci. 2013;33:8045-54 pubmed publisher
|
Planert H, Berger T, Silberberg G. Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine. PLoS ONE. 2013;8:e57054 pubmed publisher
|
Olianas M, Dedoni S, Onali P. Potentiation of dopamine D1-like receptor signaling by concomitant activation of ?- and ?-opioid receptors in mouse medial prefrontal cortex. Neurochem Int. 2012;61:1404-16 pubmed publisher
|
Gangarossa G, Valjent E. Regulation of the ERK pathway in the dentate gyrus by in vivo dopamine D1 receptor stimulation requires glutamatergic transmission. Neuropharmacology. 2012;63:1107-17 pubmed publisher
|
Hodas J, Nehring A, Höche N, Sweredoski M, Pielot R, Hess S, et al. Dopaminergic modulation of the hippocampal neuropil proteome identified by bioorthogonal noncanonical amino acid tagging (BONCAT). Proteomics. 2012;12:2464-76 pubmed publisher
|
Nikiforuk A. Dopamine D1 receptor modulation of set shifting: the role of stress exposure. Behav Pharmacol. 2012;23:434-8 pubmed publisher
|
Bradbury S, Gittings D, Schenk S. Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists. Psychopharmacology (Berl). 2012;223:389-99 pubmed
|
Knab A, Bowen R, Hamilton A, Lightfoot J. Pharmacological manipulation of the dopaminergic system affects wheel-running activity in differentially active mice. J Biol Regul Homeost Agents. 2012;26:119-29 pubmed
|
Gangarossa G, Perroy J, Valjent E. Combinatorial topography and cell-type specific regulation of the ERK pathway by dopaminergic agonists in the mouse striatum. Brain Struct Funct. 2013;218:405-19 pubmed publisher
|
Kawamoto K, Otsuguro K, Ishizuka M, Ito S. Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats. Br J Pharmacol. 2012;166:788-800 pubmed publisher
|
Hoque K, West A. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens. Synapse. 2012;66:220-31 pubmed publisher
|
Krishnan B, Genzer K, Pollandt S, Liu J, Gallagher J, Shinnick Gallagher P. Dopamine-induced plasticity, phospholipase D (PLD) activity and cocaine-cue behavior depend on PLD-linked metabotropic glutamate receptors in amygdala. PLoS ONE. 2011;6:e25639 pubmed publisher
|
KOTOWSKI S, Hopf F, Seif T, Bonci A, von Zastrow M. Endocytosis promotes rapid dopaminergic signaling. Neuron. 2011;71:278-90 pubmed publisher
|
Krawczyk M, Sharma R, Mason X, Debacker J, Jones A, Dumont E. A switch in the neuromodulatory effects of dopamine in the oval bed nucleus of the stria terminalis associated with cocaine self-administration in rats. J Neurosci. 2011;31:8928-35 pubmed publisher
|
St Onge J, Abhari H, Floresco S. Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making. J Neurosci. 2011;31:8625-33 pubmed publisher
|
Ohmura Y, Jutkiewicz E, Zhang A, Domino E. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats. Pharmacol Biochem Behav. 2011;99:552-6 pubmed publisher
|
Gangarossa G, Di Benedetto M, O Sullivan G, Dunleavy M, Alcacer C, Bonito Oliva A, et al. Convulsant doses of a dopamine D1 receptor agonist result in Erk-dependent increases in Zif268 and Arc/Arg3.1 expression in mouse dentate gyrus. PLoS ONE. 2011;6:e19415 pubmed publisher
|
Dupre K, Ostock C, Eskow Jaunarajs K, Button T, Savage L, Wolf W, et al. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats. Exp Neurol. 2011;229:288-99 pubmed publisher
|
Fiorentini C, Mattanza C, Collo G, Savoia P, Spano P, Missale C. The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. J Neurochem. 2011;117:253-63 pubmed publisher
|
Reichart D, Hinkle R, Lefever F, Dolan E, Dietrich J, Sibley D, et al. Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions. BMC Musculoskelet Disord. 2011;12:27 pubmed publisher
|
Jürgensen S, Antonio L, Mussi G, Brito Moreira J, Bomfim T, De Felice F, et al. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem. 2011;286:3270-6 pubmed publisher
|
Madsen M, Peacock L, Werge T, Andersen M, Andreasen J. Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. Neuropharmacology. 2011;60:418-22 pubmed publisher
|
Mizoguchi K, Shoji H, Tanaka Y, Tabira T. Orbitofrontal dopaminergic dysfunction causes age-related impairment of reversal learning in rats. Neuroscience. 2010;170:1110-9 pubmed publisher
|
Momiyama T. Developmental increase in D1-like dopamine receptor-mediated inhibition of glutamatergic transmission through P/Q-type channel regulation in the basal forebrain of rats. Eur J Neurosci. 2010;32:579-90 pubmed publisher
|
Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher
|
Andersen P, Jansen J. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol. 1990;188:335-47 pubmed
|
Johansen P, Hu X, White F. Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons. J Neural Transm Gen Sect. 1991;86:97-113 pubmed
|
Arnt J, Hyttel J, Sanchez C. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol. 1992;213:259-67 pubmed
|